Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity
Emily Schueddig, Veena Kochat, Emre Arslan, Y. Dallas, P. Yang, William Pedron, Z G Li, Reagan Henry, Jerome Lin, Mahinur Mattohti, Rashna Madan, Timothy A. Fields, S. Golem, S. A. Khan, Jamie Lynn Wagner, , Fariba Behbod
This study identifies stemness features in luminal hormone-responsive cells within DCIS that correlate with invasive progression and shows that targeting FOXA1 reduces tumor growth.
bioRxiv · May 16, 2026 · PreprintCancer Biology